ライフサイエンスコーパス: coronary vasodilator

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 t pain persisted despite administration of a coronary vasodilator.

2 ore and after the venous administration of a coronary vasodilator.

3 ata have suggested that it can function as a coronary vasodilator.

4 support a role for exogenous CNP as a potent coronary vasodilator.

5 Adenosine is a potent coronary vasodilator and causes an increase of coronary

6 reperfusion, and the A2 effects include both coronary vasodilator and leukocyte inhibitory effects.

7 hin the infarct bed, MCE in conjunction with coronary vasodilators can accurately predict infarct siz

8 reserve (CFR), which is a measure of overall coronary vasodilator capacity and microvascular function

9 d platelet aggregation, and are a target for coronary vasodilator drugs.

10 Coronary vasodilator dysfunction is a powerful, independ

11 nary conductance and resistance arteries the coronary vasodilator effects of the angiotensin-converti

12 Nesiritide exerts coronary vasodilator effects on both the coronary conduc

13 The improvement in coronary vasodilator function from the time of acute PTC

14 is unknown whether noninvasive assessment of coronary vasodilator function in patients with suspected

15 milar endothelium-dependent and -independent coronary vasodilator function in subjects with both type

16 Noninvasive quantitative assessment of coronary vasodilator function with positron emission tom

17 tabolic syndrome is associated with impaired coronary vasodilator function, a marker of atherosclerot

18 Statins, antiplatelet agents, and coronary vasodilators protect against microembolization

19 quantify changes in transmural perfusion and coronary vasodilator reserve (CVR), a measure of microci

20 ory dysfunction, demonstrated by an impaired coronary vasodilator reserve (CVR).

21 imed to assess the effect of TMLR on MBF and coronary vasodilator reserve (CVR).

22 ely provide a noninvasive method for testing coronary vasodilator reserve and may emerge as a new met

23 The calculated "noninvasive" and "invasive" coronary vasodilator reserve ratios were similar ([mean

24 to examine the timing and degree of regional coronary vasodilator reserve recovery in patients who ar

25 "Noninvasive" coronary vasodilator reserve was determined by measuring

26 s that correction of hyperlipidemia improves coronary vasodilator response and maximal perfusion in m

27 The coronary vasodilator response to nitroglycerin is not si

28 ical concentrations on endothelium-dependent coronary vasodilator responsiveness in postmenopausal wo

29 CNP functions as a coronary vasodilator through activation of cGMP by way o

30 receptor agonist WRC-0470 is a short-acting coronary vasodilator with potential utility for pharmaco

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。